Scabies Treatment Market: By Drug Type (Sulphur Ointment, Benzyl Benzoate Lotion, Lindane Lotion, Crotamiton Cream, Permethrin Cream, Others), By Route of Administration (Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Geography.

Purchase Option

$ 4400
$ 6600
$ 8900

Scabies Treatment Market size was valued at USD 225.8 million in 2022 and is expected to grow at 5.2% CAGR from 2023 to 2029 owing to the increased infestation of Scabies cases in hot, tropical countries and in areas of high population density. Scabies treatment includes a range of medications used to treat Scabies; a contagious itchy skin rash caused by a tiny burrowing mite called Sarcoptes scabies mite. Poverty, overcrowding, malnutrition, and lack of local expertise to recognize scabies leading to delayed diagnosis in underdeveloped and developing countries are major driving factors market. According to WHO 2023, 200 million people worldwide suffer from scabies at any one time, and more than 400 million people cumulatively every year. Moreover, rapid advancements in the healthcare and medical sector, high adoption of the latest tools and techniques, and growing funds by several public and private sectors have increased the opportunities for the advancement of the scabies treatment market. For instance, serology test and enzyme-linked immunosorbent assay (ELISA) in the last decade has proven to be highly sensitive (100%) and specific (97%) in identifying infected animals.

Furthermore, the shortage of drugs, vaccines, and medical supplies in hospitals is expected to offer industry players profitable growth opportunities in the coming years. Rising personal disposable income is another indirect element that will result in profitable market expansion potential. But, the abundance of homecare treatments and the unfavourable reimbursement environment in developing and underdeveloped economies along with high research and development expenses are expected to the growth of the scabies treatment market. However, the rising demand for targeted therapies, an increase in R&D activities for the creation of novel drugs and treatments, increased governmental awareness programs, a high prevalence of skin disorders, the disease's high contagiousness, and increased investments for the construction of healthcare infrastructure are some factors leading to the profitable growth of the market and is expected to flourish in the forecasted years.

Scabies Treatment Market Key Developments:
  • In August 2021, ParaPRO, a specialty pharma company focused on innovative anti-parasitic treatments, announced the launch of Natroba (spinosad) topical suspension.
  • In April 2021, Spinosad topical suspension 0.9%, was approved by the Food and Drug Administration for treating scabies infestations in adult and paediatric patients 4 years of age and older – a first-in-class drug and the first new scabicide approved in 31 years.

 

Scabies Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.2%

Largest Market

North America

Fastest Growing Market

Europe
Scabies Treatment Market Dynamics

Improper hygienic conditions and environmental factors are the key factor to increase the number of person affected to scabies. Moreover, low cost of drugs, increase in R&D for the innovation of newer drugs, rapid escalation of global population with poor hygienic, and increase in healthcare expenditure are anticipated to fuel the scabies treatment market. Moreover, homecare remedies for the scabies treatment and limited number of advanced therapeutics are expected to restrain the growth of scabies treatment market.

Scabies Treatment Market Segmentation

By Drug Type
  • Sulphur Ointment
  • Benzyl Benzoate Lotion
  • Lindane Lotion
  • Crotamiton Cream
  • Permethrin Cream
  • Others
By Route of Administration
  • Oral
  • Topical
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Geography
  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • Asia Pacific

Frequently Asked Questions

The scabies treatment market is projected to expand at a CAGR of 5.1% during the forecast period

Merck & Co. Inc. (U.S.), Renaissance Pharma, Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), GlaxoSmithKline plc (U.K.), Unichem Laboratories Ltd. (India), Zydus Cadila (India), Prestium Pharma, Inc. (U.S.)

North America is the fastest-growing region for the home infusion therapy devices market

Key Features of the Reports

  • The scabies treatment market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
1. Executive Summary
2. Global Scabies Treatment Market Introduction 
2.1.Global Scabies Treatment Market  - Taxonomy
2.2.Global Scabies Treatment Market  - Definitions
2.2.1.Drug Type
2.2.2.Route of Administration
2.2.3.Distribution Channel
2.2.4.Region
3. Global Scabies Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Scabies Treatment Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Scabies Treatment Market  By Drug Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Sulphur Ointment
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Benzyl Benzoate Lotion
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Lindane Lotion
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Crotamiton Cream
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Permethrin Cream
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Global Scabies Treatment Market  By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Topical
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global Scabies Treatment Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Scabies Treatment Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Drug Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Sulphur Ointment
9.1.2.Benzyl Benzoate Lotion
9.1.3.Lindane Lotion
9.1.4.Crotamiton Cream
9.1.5.Permethrin Cream
9.1.6.Others
9.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral
9.2.2.Topical
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Online Pharmacies
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Sulphur Ointment
10.1.2.Benzyl Benzoate Lotion
10.1.3.Lindane Lotion
10.1.4.Crotamiton Cream
10.1.5.Permethrin Cream
10.1.6.Others
10.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Topical
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Online Pharmacies
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Sulphur Ointment
11.1.2.Benzyl Benzoate Lotion
11.1.3.Lindane Lotion
11.1.4.Crotamiton Cream
11.1.5.Permethrin Cream
11.1.6.Others
11.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Topical
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Online Pharmacies
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Sulphur Ointment
12.1.2.Benzyl Benzoate Lotion
12.1.3.Lindane Lotion
12.1.4.Crotamiton Cream
12.1.5.Permethrin Cream
12.1.6.Others
12.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Topical
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Online Pharmacies
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Scabies Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Sulphur Ointment
13.1.2.Benzyl Benzoate Lotion
13.1.3.Lindane Lotion
13.1.4.Crotamiton Cream
13.1.5.Permethrin Cream
13.1.6.Others
13.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Topical
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Online Pharmacies
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1. Merck & Co. Inc. (U.S.)
14.2.2. Renaissance Pharma, Inc. (U.S.)
14.2.3. Sun Pharmaceutical Industries Ltd. (India)
14.2.4. GlaxoSmithKline plc (U.K.)
14.2.5. Unichem Laboratories Ltd. (India)
14.2.6. Zydus Cadila (India)
14.2.7. Prestium Pharma, Inc. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Merck & Co. Inc. (U.S.)
  • Renaissance Pharma, Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • GlaxoSmithKline plc (U.K.)
  • Unichem Laboratories Ltd. (India)
  • Zydus Cadila (India)
  • Prestium Pharma, Inc. (U.S.)

Adjacent Markets